Table 1.
Patient characteristics
| Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | |
|---|---|---|---|---|---|
| Age, year | 4 | 6 | 9 | 14 | 15 |
| Specimen used for genotyping | Muscle | Muscle | Muscle | Muscle | Muscle |
| DNA changes | c.1633G>A | c.3140A>G | c.1624G>A | c.1624G>A | c.1633G>A |
| VAF (%)a | 15 | 25 | 12 | 21 | 14 |
| Amino acid change | p.Glu545Lys | p.His1047Arg | p.Glu542Lys | p.Glu542Lys | p.Glu545Lys |
| COSMICb genomic mutation ID | COSV55873239 | COSV55873195 | COSV55873227 | COSV55873227 | COSV55873239 |
| Treatments prior to alpelisib | - | - | Botulinum toxin injections | - | Botulinum toxin injections |
Corresponds to the percentage of alternate or mutant reads to total reads detected by next-generation sequencing.
Catalogue of Somatic Mutations in Cancer.